English  |  正體中文  |  简体中文  |  Total items :2856565  
Visitors :  53394530    Online Users :  901
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"kao j h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 211-220 of 1534  (154 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-01-24T09:31:52Z Impact of hepatitis B virus infection on metabolic profiles and modifying factors Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; CHUN-JEN LIU; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; CHUN-JEN LIU; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:50Z Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy Sheng W.-H.; Hung C.-C.; Chang S.-Y.; CHUN-JEN LIU; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; Chen P.-J.; Chang S.-C.
臺大學術典藏 2022-01-24T09:31:50Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:50Z Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) Liaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.
臺大學術典藏 2022-01-24T09:31:49Z Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:49Z IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:49Z Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals CHUN-JEN LIU; Hsu C.-S.; Kao J.-H.

Showing items 211-220 of 1534  (154 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page